Analyst Joseph Pantginis of H.C. Wainwright reiterated a Buy rating on Krystal Biotech (KRYS – Research Report), retaining the price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback